EVH Evolent Health Inc

Price (delayed)

$28.83

Market cap

$2.52B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.74

Enterprise value

$2.61B

Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care ...

Highlights
The EPS has soared by 88% YoY and by 75% QoQ
Evolent Health's net income has surged by 86% YoY and by 73% QoQ
The company's equity fell by 5% YoY

Key stats

What are the main financial stats of EVH
Market
Shares outstanding
87.27M
Market cap
$2.52B
Enterprise value
$2.61B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.08
Price to sales (P/S)
2.53
EV/EBIT
N/A
EV/EBITDA
144.17
EV/Sales
2.68
Earnings
Revenue
$973.64M
EBIT
-$41.73M
EBITDA
$18.09M
Free cash flow
-$129.29M
Per share
EPS
-$0.74
Free cash flow per share
-$1.51
Book value per share
$7.07
Revenue per share
$11.39
TBVPS
$8.1
Balance sheet
Total assets
$1.29B
Total liabilities
$679.18M
Debt
$299.09M
Equity
$614.19M
Working capital
$102.28M
Liquidity
Debt to equity
0.49
Current ratio
1.25
Quick ratio
1.16
Net debt/EBITDA
5.08
Margins
EBITDA margin
1.9%
Gross margin
24.4%
Net margin
-7.3%
Operating margin
-4.2%
Efficiency
Return on assets
-5.3%
Return on equity
-11.4%
Return on invested capital
-11.1%
Return on capital employed
-4.7%
Return on sales
-4.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
-4.6%
1 week
-5.23%
1 month
10.46%
1 year
162.09%
YTD
79.85%
QTD
-7%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$973.64M
Gross profit
$237.65M
Operating income
-$41.27M
Net income
-$70.89M
Gross margin
24.4%
Net margin
-7.3%
The operating margin has soared by 92% YoY and by 84% from the previous quarter
The company's operating income has surged by 92% YoY and by 84% QoQ
The net margin has soared by 87% YoY and by 73% QoQ
Evolent Health's net income has surged by 86% YoY and by 73% QoQ

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
4.08
P/S
2.53
EV/EBIT
N/A
EV/EBITDA
144.17
EV/Sales
2.68
The EPS has soared by 88% YoY and by 75% QoQ
EVH's price to book (P/B) is 172% higher than its 5-year quarterly average of 1.5 and 70% higher than its last 4 quarters average of 2.4
The company's equity fell by 5% YoY
The price to sales (P/S) is 69% higher than the last 4 quarters average of 1.5 and 27% higher than the 5-year quarterly average of 2.0
The revenue has grown by 9% YoY

Efficiency

How efficient is Evolent Health business performance
The ROS has soared by 92% YoY and by 83% QoQ
EVH's return on invested capital has surged by 86% year-on-year and by 79% since the previous quarter
Evolent Health's return on assets has surged by 84% YoY and by 73% QoQ
The ROE has soared by 80% YoY and by 73% from the previous quarter

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 90% higher than its total liabilities
The quick ratio has grown by 17% YoY
The company's current ratio rose by 12% YoY
The debt is 51% lower than the equity
The debt has decreased by 20% YoY
EVH's debt to equity is down by 16% year-on-year but it is up by 2.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.